News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Alvotech and Advanz Achieve Global First with Golimumab Biosimilar Launch in EU and UK
Tuesday, December 23, 2025Alvotech and Advanz Pharma have launched the worlds first golimumab biosimilar in the EU and UK on December marking a significant milestone in biopharma accessibility
Cartography receives FDA IND approval and Fast Track status for CBI-1214 in colorectal cancer
Friday, December 19, 2025Cartography Biosciences has received approval from the US Food and Drug Administration FDA for its Investigational New Drug IND application for CBI the companys lead programme
European Union Reaches Landmark Agreement on Comprehensive Pharmaceutical Market Reform
Friday, December 19, 2025EU legislators have agreed on the most farreaching overhaul of the European pharmaceutical framework in over two decades reshaping incentives data exclusivity market access and RD obligations for drug makers operating in Europe
Sanofi Gains European Commission Approval for Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients
Thursday, December 18, 2025Sanofi has received European Commission approval for Sarclisa combined with VRd as a firstline treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant
Protalix Biotherapeutics and Secarna Pharmaceuticals Form Collaboration and Option Agreement
Thursday, December 18, 2025Protalix BioTherapeutics and Secarna Pharmaceuticals have entered into a collaboration and option agreement to develop new antisense oligonucleotide ASO therapies for rare kidney diseases
INCOG BioPharma Announces $200 Million Investment to Expand Operations and Grow Workforce to Nearly 1,000
Wednesday, December 17, 2025INCOG BioPharma Services has announced a further expansion with an investment of around million in its injectable drug manufacturing plant in Fishers Indiana The investment will significantly
Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
Tuesday, December 16, 2025Dren Bio a privately held clinicalstage biotechnology company has expanded its strategic collaboration with Sanofi to discover and develop a nextgeneration Bcell depletion therapy for the treatment of autoimmune diseases
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New First-Line Treatment in a Decade for HER2-Positive Metastatic Breast Cancer
Tuesday, December 16, 2025AstraZeneca and Daiichi Sankyo have received US approval for ENHERTU famtrastuzumab deruxtecannxki in combination with pertuzumab as a firstline treatment for adults with unresectable
Grifols secures full EMA approval for end-to-end Grifols Egypt plasma-derived medicines value chain to supply European markets
Tuesday, December 16, 2025Grifols has obtained European Medicines Agency approval for the entire Grifols Egypt plasmaderived medicines value chain strengthening its European supply strategy and manufacturing footprint
LEO Pharma Submits Label Expansion Application to EMA for Anzupgo in Adolescent Chronic Hand Eczema Patients
Monday, December 15, 2025LEO Pharma has submitted and received acceptance for a label expansion application to the European Medicines Agency for Anzupgo cream to include adolescent patients aged with moderate to severe chronic hand eczema
